To investigate the role of CH25H upregulation in tumor‐associated MDSCs during the disease procession, we assessed the levels of 25HC in BM‐MDSCs from mice subcutaneously implanted with MC38 tumors compared to unloaded controls using ultra performance liquid chromatography mass spectrometry (UPLC–MS/MS; Figure 2A). Here, CH25H is linked to neoplasm.